Bortezomib
Bortezomib
CAS Number: Synthetic chemistry
Description
Bortezomib is a dipeptide Boronic acid derivative and proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma.
| API Type | ICH |
| Quality | Oncology |
| Therapeutic Category | Oncology |
| Monograph Status | NA |
| Granules Product Status | Commercial Available |
| Regulatory Filing/Technical Package | US DMF |
| Innovator Brands | Velcade |
| Available dosage Form/Strength | Powder;Intravenous(3.5mg/ vial) |
Capecitabine
Capecitabine
CAS Number: 154361-50-9
Description
Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU).
| API Type | Synthetic chemistry |
| Quality | ICH |
| Therapeutic Category | Oncology |
| Monograph Status | A |
| Granules Product Status | Commercial Available |
| Regulatory Filing/Technical Package | CEP |
| Innovator Brands | Xeloda |
| Available dosage Form/Strength | Tablet (150/500 mg) |
Dasatinib
Dasatinib
CAS Number: 302962-49-8
Description
Dasatinib is a selective tyrosine kinase receptor inhibitor.
| API Type | Synthetic chemistry |
| Quality | ICH |
| Therapeutic Category | Oncology |
| Monograph Status | NA |
| Granules Product Status | Commercial Available |
| Regulatory Filing/Technical Package | US DMF |
| Innovator Brands | Sprycel |
| Available dosage Form/Strength | Tablet (20/50/70/80/100/140mg) |
